Biotech CMOs drive innovation with expanded CDMO services, new facilities, and global outreach, supporting drug development, manufacturing, and market growth.
Global biopharma logistics are evolving as pharma supply challenges rise. Discover how couriers are tackling the main regulatory and sustainability issues.
LINDIS Biotech partners with Celonic Group for GMP manufacturing of catumaxomab, the only EMA-approved targeted therapy for malignant ascites treatment.
Novartis acquires Anthos Therapeutics for $925M, strengthening its late-stage cardiovascular pipeline and advancing innovative heart health treatments.
Bio-Rad to acquire Stilla Technologies, enhancing its digital PCR portfolio and expanding genomics research and clinical diagnostics capabilities globally.
